Omadacycline OverviewOmadacycline, sold under the brand name Nuzyra, is a broad spectrum antibiotic medication belonging to the aminomethylcycline subclass of tetracycline antibiotics. In the United States, it was approved in October 2018, for the treatment of community-acquired bacterial pneumonia and acute skin and skin structure infections. Contents 1 In vitro studies 2 Mechanism of action 3 Clinical trials 4 Discovery 5 References 6 External links In vitro studies In vitro studies h...
Read more Omadacycline Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Omadacycline
Recent Omadacycline Forums:Be the first to start a discussion about this drug.
Possible Dosages for this and Related Drugs:
- Powder: 100mg/vial
- Tablet: 150mg
Other drugs which contain Omadacycline or a similar ingredient: (1 result)
- NUZYRA Omadacycline Tosylate